• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞外基质蛋白和癌胚抗原相关细胞粘附分子是胰腺癌患者胰管液外泌体的特征。

Extracellular matrix proteins and carcinoembryonic antigen-related cell adhesion molecules characterize pancreatic duct fluid exosomes in patients with pancreatic cancer.

作者信息

Zheng Jian, Hernandez Jonathan M, Doussot Alexandre, Bojmar Linda, Zambirinis Constantinos P, Costa-Silva Bruno, van Beek Elke J A H, Mark Milica T, Molina Henrik, Askan Gokce, Basturk Olca, Gonen Mithat, Kingham T Peter, Allen Peter J, D'Angelica Michael I, DeMatteo Ronald P, Lyden David, Jarnagin William R

机构信息

Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Children's Cancer and Blood Foundation Laboratories, Department of Pediatrics, Drukier Institute for Children's Health, Meyer Cancer Center, Weill Cornell Medical College, New York, NY, USA; Department of Cell and Developmental Biology, Drukier Institute for Children's Health, Meyer Cancer Center, Weill Cornell Medical College, New York, NY, USA.

出版信息

HPB (Oxford). 2018 Jul;20(7):597-604. doi: 10.1016/j.hpb.2017.12.010. Epub 2018 Jan 12.

DOI:10.1016/j.hpb.2017.12.010
PMID:29339034
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6779041/
Abstract

BACKGROUND

Exosomes are nanovesicles that have been shown to mediate carcinogenesis in pancreatic ductal adenocarcinoma (PDAC). Given the direct communication of pancreatic duct fluid with the tumor and its relative accessibility, we aimed to determine the feasibility of isolating and characterizing exosomes from pancreatic duct fluid.

METHODS

Pancreatic duct fluid was collected from 26 patients with PDAC (n = 13), intraductal papillary mucinous neoplasm (IPMN) (n = 8) and other benign pancreatic diseases (n = 5) at resection. Exosomes were isolated by serial ultracentrifugation, proteins were identified by mass spectrometry, and their expression was evaluated by immunohistochemistry.

RESULTS

Exosomes were isolated from all specimens with a mean concentration of 5.9 ± 1 × 10 particles/mL and most frequent size of 138 ± 9 nm. Among the top 35 proteins that were significantly associated with PDAC, multiple carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) and extracellular matrix (ECM) proteins were identified. Interestingly, CEACAM 1/5 expression by immunohistochemistry was seen only on tumor epithelia whereas tenascin C positivity was restricted to stroma, suggesting that both tumor and stromal cells contributed to exosomes.

CONCLUSION

This is the first study showing that exosome isolation is feasible from pancreatic duct fluid, and that exosomal proteins may be utilized to diagnose patients with PDAC.

摘要

背景

外泌体是一种纳米囊泡,已被证明在胰腺导管腺癌(PDAC)的致癌过程中起介导作用。鉴于胰管液与肿瘤的直接连通性及其相对易获取性,我们旨在确定从胰管液中分离和鉴定外泌体的可行性。

方法

在手术切除时,从26例PDAC患者(n = 13)、导管内乳头状黏液性肿瘤(IPMN)患者(n = 8)和其他良性胰腺疾病患者(n = 5)中收集胰管液。通过连续超速离心分离外泌体,用质谱法鉴定蛋白质,并通过免疫组织化学评估其表达。

结果

从所有标本中均分离出外泌体,平均浓度为5.9±1×10颗粒/毫升,最常见的大小为138±9纳米。在与PDAC显著相关的前35种蛋白质中,鉴定出多种癌胚抗原相关细胞黏附分子(CEACAMs)和细胞外基质(ECM)蛋白。有趣的是,免疫组织化学检测显示CEACAM 1/5仅在肿瘤上皮细胞上表达,而腱生蛋白C阳性仅限于基质,这表明肿瘤细胞和基质细胞都对外泌体有贡献。

结论

这是第一项表明从胰管液中分离外泌体是可行的研究,并且外泌体蛋白可用于诊断PDAC患者。

相似文献

1
Extracellular matrix proteins and carcinoembryonic antigen-related cell adhesion molecules characterize pancreatic duct fluid exosomes in patients with pancreatic cancer.细胞外基质蛋白和癌胚抗原相关细胞粘附分子是胰腺癌患者胰管液外泌体的特征。
HPB (Oxford). 2018 Jul;20(7):597-604. doi: 10.1016/j.hpb.2017.12.010. Epub 2018 Jan 12.
2
Cancerization of the Pancreatic Ducts: Demonstration of a Common and Under-recognized Process Using Immunolabeling of Paired Duct Lesions and Invasive Pancreatic Ductal Adenocarcinoma for p53 and Smad4 Expression.胰腺导管癌变:通过对配对的导管病变和侵袭性胰腺导管腺癌进行 p53 和 Smad4 表达的免疫标记,显示一种常见且未被充分认识的过程。
Am J Surg Pathol. 2018 Nov;42(11):1556-1561. doi: 10.1097/PAS.0000000000001148.
3
The carcinoembryonic antigen level in pancreatic juice and mural nodule size are predictors of malignancy for branch duct type intraductal papillary mucinous neoplasms of the pancreas.胰液中的癌胚抗原水平和壁结节大小是胰腺分支胰管型导管内乳头状黏液性肿瘤恶性的预测指标。
Ann Surg. 2012 Mar;255(3):517-22. doi: 10.1097/SLA.0b013e3182444231.
4
Long-term Risk of Malignancy in Branch-Duct Intraductal Papillary Mucinous Neoplasms.分支状-乳头部管状乳头状黏液性肿瘤的长期恶性风险。
Gastroenterology. 2020 Jan;158(1):226-237.e5. doi: 10.1053/j.gastro.2019.08.032. Epub 2019 Aug 29.
5
Loss of Trefoil Factor 2 From Pancreatic Duct Glands Promotes Formation of Intraductal Papillary Mucinous Neoplasms in Mice.胰腺导管腺体重三叶因子2缺失促进小鼠导管内乳头状黏液性肿瘤的形成。
Gastroenterology. 2016 Dec;151(6):1232-1244.e10. doi: 10.1053/j.gastro.2016.07.045. Epub 2016 Aug 12.
6
Evaluation of SOX9 expression in pancreatic ductal adenocarcinoma and intraductal papillary mucinous neoplasm.评估胰腺导管腺癌和导管内乳头状黏液性肿瘤中 SOX9 的表达。
Pancreas. 2013 Apr;42(3):488-93. doi: 10.1097/MPA.0b013e318269d281.
7
Immunohistochemical FAP Expression Reflects Ga-FAPI PET Imaging Properties of Low- and High-Grade Intraductal Papillary Mucinous Neoplasms and Pancreatic Ductal Adenocarcinoma.免疫组化 FAP 表达反映低级别和高级别导管内乳头状黏液性肿瘤和胰腺导管腺癌的 Ga-FAPI PET 成像特性。
J Nucl Med. 2024 Jan 2;65(1):52-58. doi: 10.2967/jnumed.123.266393.
8
Surgical indication for intraductal papillary mucinous neoplasm without mural nodule ≥5 mm.无壁结节≥5mm 的导管内乳头状黏液性肿瘤的手术指征。
Surgery. 2021 Feb;169(2):388-395. doi: 10.1016/j.surg.2020.07.005. Epub 2020 Aug 26.
9
Segmental Versus Diffuse Main Duct Intraductal Papillary Mucinous Neoplasm: Examination of Main Pancreatic Duct Morphology and Implications for Malignancy Risk and Extent of Surgical Resection.节段性与弥漫性主胰管内乳头状黏液性肿瘤:主胰管形态学检查及其对恶性风险和手术切除范围的影响。
Ann Surg. 2023 Jul 1;278(1):110-117. doi: 10.1097/SLA.0000000000005672. Epub 2022 Aug 11.
10
Carcinoembryonic antigen level in the pancreatic juice is effective in malignancy diagnosis and prediction of future malignant transformation of intraductal papillary mucinous neoplasm of the pancreas.胰液中的癌胚抗原水平对恶性肿瘤的诊断和预测胰腺导管内乳头状黏液性肿瘤的未来恶性转化具有一定的效果。
J Gastroenterol. 2019 Nov;54(11):1029-1037. doi: 10.1007/s00535-019-01592-8. Epub 2019 May 20.

引用本文的文献

1
Proteomics in pancreatic cancer.胰腺癌中的蛋白质组学
Biomark Res. 2025 Jul 6;13(1):93. doi: 10.1186/s40364-025-00805-y.
2
Post-Secretion Processes and Modification of Extracellular Vesicles.细胞外囊泡的分泌后过程与修饰
Cells. 2025 Mar 11;14(6):408. doi: 10.3390/cells14060408.
3
The Past, Present, and Future of Biomarkers for the Early Diagnosis of Pancreatic Cancer.胰腺癌早期诊断生物标志物的过去、现在与未来
Biomedicines. 2024 Dec 13;12(12):2840. doi: 10.3390/biomedicines12122840.
4
Composition, functions, and applications of exosomal membrane proteins.外泌体膜蛋白的组成、功能和应用。
Front Immunol. 2024 Aug 1;15:1408415. doi: 10.3389/fimmu.2024.1408415. eCollection 2024.
5
Lectins as potential tools for cancer biomarker discovery from extracellular vesicles.凝集素作为从细胞外囊泡中发现癌症生物标志物的潜在工具。
Biomark Res. 2023 Sep 29;11(1):85. doi: 10.1186/s40364-023-00520-6.
6
Current status of molecular diagnostic approaches using liquid biopsy.液体活检中应用的分子诊断方法的现状。
J Gastroenterol. 2023 Sep;58(9):834-847. doi: 10.1007/s00535-023-02024-4. Epub 2023 Jul 20.
7
Exosomes from Human Umbilical Cord Mesenchymal Stem Cells Facilitates Injured Endometrial Restoring in Early Repair Period through miR-202-3p Mediating Formation of ECM.人脐带间充质干细胞来源的外泌体通过 miR-202-3p 介导 ECM 形成促进早期修复期受损子宫内膜的修复。
Stem Cell Rev Rep. 2023 Aug;19(6):1954-1964. doi: 10.1007/s12015-023-10549-7. Epub 2023 May 25.
8
Diagnostic Bioliquid Markers for Pancreatic Cancer: What We Have vs. What We Need.胰腺癌的诊断性生物液体标志物:我们已有的与我们需要的。
Cancers (Basel). 2023 Apr 25;15(9):2446. doi: 10.3390/cancers15092446.
9
Current Applications of Liquid Biopsy in Gastrointestinal Cancer Disease-From Early Cancer Detection to Individualized Cancer Treatment.液体活检在胃肠癌疾病中的当前应用——从早期癌症检测到个体化癌症治疗
Cancers (Basel). 2023 Mar 23;15(7):1924. doi: 10.3390/cancers15071924.
10
Biology of Tenascin C and its Role in Physiology and Pathology.Tenascin C 的生物学特性及其在生理学和病理学中的作用。
Curr Med Chem. 2024;31(19):2706-2731. doi: 10.2174/0929867330666230404124229.

本文引用的文献

1
Elevated glypican-1 expression is associated with an unfavorable prognosis in pancreatic ductal adenocarcinoma.糖蛋白 1 表达升高与胰腺导管腺癌的不良预后相关。
Cancer Med. 2017 Jun;6(6):1181-1191. doi: 10.1002/cam4.1064. Epub 2017 Apr 24.
2
A microRNA signature in circulating exosomes is superior to exosomal glypican-1 levels for diagnosing pancreatic cancer.循环外泌体中的微小RNA特征在诊断胰腺癌方面优于外泌体磷脂酰肌醇蛋白聚糖-1水平。
Cancer Lett. 2017 May 1;393:86-93. doi: 10.1016/j.canlet.2017.02.019. Epub 2017 Feb 20.
3
MVP-mediated exosomal sorting of miR-193a promotes colon cancer progression.MVP 介导的 miR-193a 外泌体分拣促进结肠癌进展。
Nat Commun. 2017 Feb 17;8:14448. doi: 10.1038/ncomms14448.
4
Genetic analyses of isolated high-grade pancreatic intraepithelial neoplasia (HG-PanIN) reveal paucity of alterations in TP53 and SMAD4.对孤立性高级别胰腺上皮内瘤变(HG-PanIN)的基因分析显示,TP53和SMAD4的改变很少。
J Pathol. 2017 May;242(1):16-23. doi: 10.1002/path.4884. Epub 2017 Mar 30.
5
Stromal cues regulate the pancreatic cancer epigenome and metabolome.基质信号调节胰腺癌的表观基因组和代谢组。
Proc Natl Acad Sci U S A. 2017 Jan 31;114(5):1129-1134. doi: 10.1073/pnas.1620164114. Epub 2017 Jan 17.
6
SEOM Clinical Guideline for the treatment of pancreatic cancer (2016).SEOM胰腺癌治疗临床指南(2016年)
Clin Transl Oncol. 2016 Dec;18(12):1172-1178. doi: 10.1007/s12094-016-1586-x. Epub 2016 Nov 28.
7
Plasma Proteome Profiling to Assess Human Health and Disease.血浆蛋白质组谱分析评估人类健康和疾病。
Cell Syst. 2016 Mar 23;2(3):185-95. doi: 10.1016/j.cels.2016.02.015.
8
Extracellular vesicles: masters of intercellular communication and potential clinical interventions.细胞外囊泡:细胞间通讯的掌控者及潜在的临床干预手段
J Clin Invest. 2016 Apr 1;126(4):1139-43. doi: 10.1172/JCI87316.
9
Pancreatic Cancer Exosomes: Shedding Off for a Meaningful Journey.胰腺癌外泌体:踏上意义非凡的旅程。
Pancreat Disord Ther. 2016;6(2):e148. doi: 10.4172/2165-7092.1000e148.
10
A Pilot Study Evaluating Serum MMP7 as a Preoperative Prognostic Marker for Pancreatic Ductal Adenocarcinoma Patients.一项评估血清基质金属蛋白酶7作为胰腺导管腺癌患者术前预后标志物的初步研究。
J Gastrointest Surg. 2016 May;20(5):899-904. doi: 10.1007/s11605-015-3057-z. Epub 2016 Feb 26.